Log In
Print this Print this

Namzaric, memantine ER/donepezil (ADS-8704, MDX-8704)

Also known as: formerly Arimenda, Arimenda

  Manage Alerts
Collapse Summary General Information
Company Adamas Pharmaceuticals Inc.
DescriptionOnce-daily, fixed-dose combination of memantine ER, a NMDA receptor antagonist, and donepezil, an acetylcholinesterase (AChE) inhibitor
Molecular Target NMDA receptor ; Acetylcholinesterase (AChE)
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor; NMDA receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat moderate to severe Alzheimer's dementia
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today